首页> 外文期刊>Journal of Korean medical science >Microalbuminuria is independently associated with arterial stiffness and vascular inflammation but not with carotid intima-media thickness in patients with newly diagnosed type 2 diabetes or essential hypertension
【24h】

Microalbuminuria is independently associated with arterial stiffness and vascular inflammation but not with carotid intima-media thickness in patients with newly diagnosed type 2 diabetes or essential hypertension

机译:在新诊断为2型糖尿病或原发性高血压的患者中,微量白蛋白尿与动脉僵硬度和血管炎症独立相关,但与颈动脉内膜中层厚度无关

获取原文
获取原文并翻译 | 示例
           

摘要

The association between microalbuminuria (MAU) and the indices of macrovascular complication in patients with newly diagnosed type 2 diabetes (D) or essential hypertension (H) was evaluated. Total 446 patients were classified into four groups according to the urinary albumin-to-creatinine ratio: MAU-D (n = 104), normoalbuminuria (NAU)-D (n = 114), MAU-H (n = 116), and NAU-H (n = 112). The indices of macrovascular complication including arterial stiffness evaluated by pulse-wave-velocity (PWV), carotid intima-media thickness (IMT), and vascular inflammation marked by high-sensitivity C-reactive protein (hsCRP) were assessed. PWV, IMT, and hsCRP were higher in patients with MAU than in those with NAU in both diabetes and hypertension groups. In both MAU-D and MAU-H groups, PWV and hsCRP levels were positively correlated with MAU level (MAU-D: r = 0.47, 0.41, MAU-H: r = 0.36, 0.62, respectively, P < 0.05). Additionally, PWV and hsCRP were independent factors predicting MAU (diabetes group: OR 1.85, 1.54, hypertension group: OR 1.38, 1.51, respectively, P < 0.001), but not IMT. MAU is independently associated with arterial stiffness and vascular inflammation but not with IMT in patients with newly diagnosed type 2 diabetes or essential hypertension, which emphasizes the importance of proactive clinical investigations for atherosclerotic complications in patients with MAU, even in newly diagnosed diabetes or hypertension.
机译:评估了新诊断的2型糖尿病(D)或原发性高血压(H)患者的微量白蛋白尿(MAU)与大血管并发症指数之间的关联。根据尿白蛋白与肌酐的比例,将446位患者分为四组:MAU-D(n = 104),正常白蛋白尿(NAU)-D(n = 114),MAU-H(n = 116)和NAU-H(n = 112)。评估大血管并发症的指数,包括通过脉搏波速度(PWV),颈动脉内膜中层厚度(IMT)和以高敏C反应蛋白(hsCRP)为标志的血管炎症评估的动脉僵硬度。在糖尿病和高血压组中,MAU患者的PWV,IMT和hsCRP均高于NAU患者。在MAU-D和MAU-H组中,PWV和hsCRP水平均与MAU水平呈正相关(MAU-D:r = 0.47、0.41,MAU-H:r = 0.36、0.62,P <0.05)。此外,PWV和hsCRP是预测MAU的独立因素(糖尿病组:OR 1.85,1.54,高血压组:OR 1.38,1.51,P <0.001),但不是IMT。在新诊断的2型糖尿病或原发性高血压患者中,MAU与动脉僵硬度和血管炎症独立相关,但与IMT无关,这强调了对MAU患者的动脉粥样硬化并发症进行积极的临床研究的重要性,即使在新诊断的糖尿病或高血压中也是如此。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号